you are viewing a single comment's thread.
We will rock in anticipation of Ceplene approval. That's only 1 catalyst that will drive this stock higher. Epicept has many irons in the fire. Even management can't screw all of them up! Patience! It's not easy, but fortunes are never easy to make!